Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024

BUY
$8.63 - $12.56 $15,930 - $23,185
1,846 Added 10.44%
19,525 $181,000
Q1 2024

Apr 29, 2024

BUY
$9.86 - $13.74 $62,887 - $87,633
6,378 Added 56.44%
17,679 $218,000
Q4 2023

Feb 07, 2024

BUY
$7.1 - $10.89 $80,237 - $123,067
11,301 New
11,301 $123,000
Q2 2023

Aug 07, 2023

SELL
$8.59 - $14.56 $52,218 - $88,510
-6,079 Reduced 4.62%
125,611 $1.2 Million
Q1 2023

May 09, 2023

SELL
$9.53 - $16.8 $23,739 - $41,848
-2,491 Reduced 1.86%
131,690 $1.58 Million
Q4 2022

Feb 09, 2023

SELL
$8.71 - $14.28 $37,095 - $60,818
-4,259 Reduced 3.08%
134,181 $1.87 Million
Q3 2022

Nov 09, 2022

SELL
$7.19 - $9.91 $12,769 - $17,600
-1,776 Reduced 1.27%
138,440 $1.26 Million
Q2 2022

Aug 10, 2022

SELL
$5.78 - $8.87 $56,499 - $86,704
-9,775 Reduced 6.52%
140,216 $1.12 Million
Q1 2022

May 09, 2022

BUY
$5.14 - $9.35 $92,951 - $169,085
18,084 Added 13.71%
149,991 $934,000
Q4 2021

Feb 09, 2022

SELL
$8.71 - $13.77 $27,297 - $43,155
-3,134 Reduced 2.32%
131,907 $1.32 Million
Q3 2021

Nov 09, 2021

SELL
$10.35 - $15.65 $1,055 - $1,596
-102 Reduced 0.08%
135,041 $1.54 Million
Q2 2021

Aug 10, 2021

BUY
$12.25 - $14.87 $14,687 - $17,829
1,199 Added 0.9%
135,143 $1.91 Million
Q1 2021

May 10, 2021

BUY
$12.28 - $19.74 $1,350 - $2,171
110 Added 0.08%
133,944 $2.05 Million
Q4 2020

Feb 08, 2021

SELL
$11.65 - $17.94 $60,381 - $92,983
-5,183 Reduced 3.73%
133,834 $1.8 Million
Q3 2020

Nov 06, 2020

BUY
$12.98 - $25.98 $324,188 - $648,876
24,976 Added 21.9%
139,017 $2.2 Million
Q2 2020

Aug 05, 2020

BUY
$9.06 - $23.49 $1.03 Million - $2.68 Million
114,041 New
114,041 $2.84 Million

Others Institutions Holding ZYXI

About ZYNEX INC


  • Ticker ZYXI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 37,453,400
  • Market Cap $306M
  • Description
  • Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and n...
More about ZYXI
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.